FDA OKs Talzenna, enzalutamide combo for prostate cancer

Coverage, in order

1. 15d ago
   
   Healio indie

   FDA OKs Talzenna, enzalutamide combo for prostate cancer

   The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen pathway modulation-naive or -sensitive prostate cancer with homologous recombination repair gene mutations. “This approval represents a critical advancement for patients with…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.